4//SEC Filing
Perfetti Riccardo 4
Accession 0001209191-23-003289
CIK 0001697532other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:32 PM ET
Size
7.2 KB
Accession
0001209191-23-003289
Insider Transaction Report
Form 4
Perfetti Riccardo
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-01-11$0.91/sh−6,053$5,508→ 154,856 total - Award
Common Stock
2023-01-11+550,000→ 704,856 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 11, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001775410
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:32 PM ET
- Size
- 7.2 KB